---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-23-000004"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:39:08.222768+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q4 preliminary revenue $31M (+25% YoY); FY22 $122.3M (+25%); guides FY23 $146-149M

## Summary
- Preliminary Q4 2022 net revenue $31.0M, up 25% vs $24.8M in Q4 2021.
- Full year 2022 preliminary net revenue $122.3M, up 25% from $98.0M in 2021.
- Domestic Q4 revenue +15% YoY; international Q4 revenue +67% YoY.
- FY 2023 guidance: net revenue $146M-$149M, implying 20-22% growth.
- CEO cites viral respiratory infection disruptions at children's hospitals as a headwind.

## SEC filing metadata
- accession: 0001425450-23-000004
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000004/0001425450-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000004/kids-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-23-000004
- JSON: https://secwatch.observer/filing/0001425450-23-000004.json
- Plain text: https://secwatch.observer/filing/0001425450-23-000004.txt

## Key facts
- Earnings Releases
  ORTHOPEDIATRICS CORP updated its fourth quarter and full year ended December 31, 2022 guidance (initiated).
  - Period: fourth quarter and full year ended December 31, 2022
  - Guidance: initiated
  - Result: preliminary results
  source text: On January 9, 2023, OrthoPediatrics Corp. (the "Company”) issued a press release announcing its preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2022, providing management's projection of 2023 net revenue and providing a related business update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545023000004/0001425450-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.